Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded promising discoveries into new therapeutic approaches. Current efforts centers on targeting the underlying pathophysiology of MSA. One avenue under investigation involves drug-based interventions to influence the activity of